NanoViricides Inc NNVC:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 05/03/24 EDT
1.13quote price arrow down-0.07 (-5.83%)
Volume
26,333
52 week range
1.00 - 2.00
Loading...
  • Open1.12
  • Day High1.17
  • Day Low1.10
  • Prev Close1.20
  • 52 Week High2.00
  • 52 Week High Date07/11/23
  • 52 Week Low1.00
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap13.31M
  • Shares Out11.78M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.75
  • YTD % Change10.78

KEY STATS

  • Open1.12
  • Day High1.17
  • Day Low1.10
  • Prev Close1.20
  • 52 Week High2.00
  • 52 Week High Date07/11/23
  • 52 Week Low1.00
  • 52 Week Low Date11/13/23
  • Market Cap13.31M
  • Shares Out11.78M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.75
  • YTD % Change10.78

RATIOS/PROFITABILITY

  • EPS (TTM)-0.80
  • P/E (TTM)-1.41
  • Fwd P/E (NTM)-2.90
  • EBITDA (TTM)-8.948M
  • ROE (TTM)-57.90%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On NanoViricides Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
NanoViricides, Inc. is a development stage company, which is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Its lead drug candidate is NV-CoV-2 (API NV-387) for the treatment of COVID-19 disease caused by SARS-CoV-2 coronavirus. Its other advanced candidate is NV-HHV-1 for the treatment of Shingles. NV-CoV-2 is its...
Anil Diwan Ph.D.
President, Chief Executive Officer, Executive Chairman of the Board
Meeta Vyas
Chief Financial Officer
Address
1 Controls Drive
Shelton, CT
06484
United States

Top Peers

SYMBOLLASTCHG%CHG
KPRX
Kiora Pharmaceuticals Inc
0.5133-0.0293-5.3999%
IMNN
Imunon Inc
1.33+0.02+1.53%
COEP
Coeptis Therapeutics Holdings Inc
0.36-0.0096-2.5974%
GNPX
Genprex Inc
2.38+0.02+0.85%
NCNA
NuCana PLC
3.95-0.01-0.38%